The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
07/03/2025

Valereum Plc
("Valereum", "VLRM" or the "Company")
Deal Completion Update
Valereum Plc (AQSE: VLRM) provides an update on the £19 million subscription by Valereum Inc., and the £1 million subscription by the institutional investor, announced on 20 February 2025. Completion, initially expected on or around 4 March, has been extended to support the transaction, including relevant due diligence and receipt of source of funds and information required to satisfy KYC / AML laws.
The Board and DMC remain confident about the progress and expect completion in due course.
We will look to update the market when appropriate.
For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub. Here you will find all company news and additional content to further explain Valereum's strategy and products.
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
|
Valereum Plc Peter Sekhon, Investor Relation Director Engage with the company directly |
Tel: +44 7938 767319 |
|
Stanford Capital Partners Bob Pountney/ Patrick Claridge |
Tel: +44 023 3650 3650 |
|
AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge / Gabrielle Cordeiro
|
Tel: +44 20 3855 5551 |
For more information, please visit the Company's website at www.vlrm.com or to engage with the Valereum management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.
Navigate to our Interactive Investor hub here: Sign Up